Login / Signup
Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcoma.
Tarek Assi
Rebecca Ibrahim
Toni Ibrahim
Rita Khoury
Axel Le Cesne
Published in:
Immunotherapy (2023)
Keyphrases
</>